Insider trading

Period: 120 months Stock: ANIP + Add filter Clear all
Views & alerts

Save your view. Keep the filter you have built, and get an email when a new filing matches it. A free account does both.

When

Period

How far back the list reaches. Filings arrive days after the trade, so the newest rows always lag a little.

241 decisions over 120 months
Who

Role

The position the person holds at the company, read from the title on the filing. A chief executive who is also a director counts as the chief executive.

241 decisions over 120 months
The trade

Type of trade

Purchases, sales, or cluster buys: companies where 3 or more insiders bought within 30 days. The number beside each is what that choice would give.

241 decisions over 120 months
The trade

Minimum amount

Hides rows under this value. The amount is the shares traded times the price on the filing.

241 decisions over 120 months
The trade

Plan

  • Discretionary: they chose to sell that week.
  • Scheduled: a 10b5-1 plan fixed the sale months in advance, so the timing says nothing about what they knew.
  • Not stated: filed before the SEC added the box in April 2023, which is most of the older half of this database.
241 decisions over 120 months
The trade

Share of their own holding

How much of what they already held the trade moved. Selling a tenth of a stake is not the same act as selling all of it.

At least
241 decisions over 120 months
Ownership

What the chief executive holds

The value of the chief executive’s stock measured against base salary. The salary comes from the company’s own proxy. Companies with no figure are in neither direction.

241 decisions over 120 months
Stock
Insider
Type ?
Why it stands out
13 Jun 2024
Cook Meredith SR. VP, GENERAL COUNSEL & SEC.
Sold on a plan
$15.95K 250 at 63.80
0.4%
Planned (10b5-1)
5 Jun 2024
Gutwerg Ori SVP, GENERICS
Sold at will
$200.00K 2,985 at 67.00
3.7%
Not planned
4 Jun 2024
CAREY STEPHEN P. SVP & CFO
Sold at will
$317.90K 5,000 at 63.58
3.0%
Not planned
3 Jun 2024
Gassert Chad SVP - CORP. DEV. & STRATEGY · indirect
Sold on a plan
$1.29M 20,000 at 64.41
8.6%
Planned (10b5-1)
21 May 2024
Mutz Christopher HEAD OF RARE DISEASE
Sold at will
$123.22K 2,000 at 61.61
2.3%
Not planned
20 May 2024
Shanmugam Muthusamy HEAD OF R&D, COO-NOVITIUM OPS · indirect
Sold on a plan
$794.57K 12,855 at 61.81
1.7%
Planned (10b5-1)
17 May 2024
Shanmugam Muthusamy HEAD OF R&D, COO-NOVITIUM OPS · indirect
Sold on a plan
$362.36K 5,836 at 62.09
0.8%
Planned (10b5-1)
16 May 2024
Shanmugam Muthusamy HEAD OF R&D, COO-NOVITIUM OPS · indirect
Sold on a plan
$1.05M 16,459 at 63.84
2.1%
Planned (10b5-1)
16 May 2024
Sold at will
$127.74K 2,000 at 63.87
9.9%
Not planned
15 May 2024
Shanmugam Muthusamy HEAD OF R&D, COO-NOVITIUM OPS · indirect
Sold on a plan
$978.02K 14,850 at 65.86
1.9%
Planned (10b5-1)
14 May 2024
Lalwani Nikhil PRESIDENT & CEO
Sold at will
$1.10M 16,669 at 66.10
4.2%
Not planned
13 May 2024
Cook Meredith SR. VP, GENERAL COUNSEL & SEC.
Sold on a plan
$16.92K 250 at 67.69
0.4%
Planned (10b5-1)
1 May 2024
Gassert Chad SVP - CORP. DEV. & STRATEGY · indirect
Sold on a plan
$1.33M 20,000 at 66.62
7.9%
Planned (10b5-1)
19 Apr 2024
Shanmugam Muthusamy HEAD OF R&D, COO-NOVITIUM OPS · indirect
Sold on a plan
$1.10M 16,809 at 65.17
2.1%
Planned (10b5-1)
18 Apr 2024
Shanmugam Muthusamy HEAD OF R&D, COO-NOVITIUM OPS · indirect
Sold on a plan
$677.29K 10,423 at 64.98
1.3%
Planned (10b5-1)
17 Apr 2024
Shanmugam Muthusamy HEAD OF R&D, COO-NOVITIUM OPS · indirect
Sold on a plan
$622.61K 9,520 at 65.40
1.2%
Planned (10b5-1)
16 Apr 2024
Shanmugam Muthusamy HEAD OF R&D, COO-NOVITIUM OPS · indirect
Sold on a plan
$386.21K 5,834 at 66.20
0.7%
Planned (10b5-1)
15 Apr 2024
Shanmugam Muthusamy HEAD OF R&D, COO-NOVITIUM OPS · indirect
Sold on a plan
$491.77K 7,414 at 66.33
0.9%
Planned (10b5-1)
12 Apr 2024
Cook Meredith SR. VP, GENERAL COUNSEL & SEC.
Sold on a plan
$16.95K 250 at 67.79
0.4%
Planned (10b5-1)
1 Apr 2024
Gassert Chad SVP - CORP. DEV. & STRATEGY · indirect
Sold on a plan
$1.35M 20,000 at 67.25
7.3%
Planned (10b5-1)
13 Mar 2024
Cook Meredith SR. VP, GENERAL COUNSEL & SEC.
Sold on a plan
$16.64K 250 at 66.54
0.4%
Planned (10b5-1)
11 Mar 2024
Gassert Chad SVP - CORP. DEV. & STRATEGY · indirect
Sold on a plan
$1.32M 20,000 at 65.81
6.8%
Planned (10b5-1)
11 Mar 2024
CAREY STEPHEN P. SVP & CFO
Sold at will
$510.44K 7,787 at 65.55
4.2%
Not planned
8 Mar 2024
Lalwani Nikhil PRESIDENT & CEO
Sold at will
$1.09M 16,292 at 67.13
3.8%
Not planned
8 Mar 2024
Shanmugam Muthusamy HEAD OF R&D, COO-NOVITIUM OPS · indirect
Sold on a plan
$671.70K 10,000 at 67.17
1.2%
Planned (10b5-1)
7 Mar 2024
Marken James G. SVP OPS & PROD DEV
Sold at will
$1.62M 24,338 at 66.37
16.4%
Not planned
7 Mar 2024
Shanmugam Muthusamy HEAD OF R&D, COO-NOVITIUM OPS · indirect
Sold on a plan
$1.00M 15,085 at 66.35
1.8%
Planned (10b5-1)
6 Mar 2024
Lalwani Nikhil PRESIDENT & CEO
Sold at will
$1.90M 28,965 at 65.52
6.1%
Not planned
6 Mar 2024
Shanmugam Muthusamy HEAD OF R&D, COO-NOVITIUM OPS · indirect
Sold on a plan
$970.40K 14,822 at 65.47
1.7%
Planned (10b5-1)
5 Mar 2024
Shanmugam Muthusamy HEAD OF R&D, COO-NOVITIUM OPS · indirect
Sold on a plan
$659.58K 10,093 at 65.35
1.1%
Planned (10b5-1)
5 Mar 2024
Mutz Christopher HEAD OF RARE DISEASE
Sold at will
$330.00K 5,000 at 66.00
5.4%
Not planned
4 Mar 2024
Pera Antonio R Director
Sold at will
$456.40K 7,000 at 65.20
20.8%
Not planned
13 Feb 2024
Cook Meredith SR. VP, GENERAL COUNSEL & SEC.
Sold on a plan
$14.01K 250 at 56.04
0.7%
Planned (10b5-1)
23 Jan 2024
Shanmugam Muthusamy HEAD OF R&D, COO-NOVITIUM OPS · indirect
Sold on a plan
$846.60K 15,000 at 56.44
1.7%
Planned (10b5-1)
22 Jan 2024
Shanmugam Muthusamy HEAD OF R&D, COO-NOVITIUM OPS · indirect
Sold on a plan
$318.47K 5,692 at 55.95
0.6%
Planned (10b5-1)
19 Jan 2024
Shanmugam Muthusamy HEAD OF R&D, COO-NOVITIUM OPS · indirect
Sold on a plan
$251.40K 4,524 at 55.57
0.5%
Planned (10b5-1)
18 Jan 2024
Shanmugam Muthusamy HEAD OF R&D, COO-NOVITIUM OPS · indirect
Sold on a plan
$541.06K 9,784 at 55.30
1.1%
Planned (10b5-1)
17 Jan 2024
Shanmugam Muthusamy HEAD OF R&D, COO-NOVITIUM OPS · indirect
Sold on a plan
$551.10K 10,000 at 55.11
1.1%
Planned (10b5-1)
16 Jan 2024
Shanmugam Muthusamy HEAD OF R&D, COO-NOVITIUM OPS · indirect
Sold on a plan
$278.15K 5,000 at 55.63
0.5%
Planned (10b5-1)
12 Jan 2024
Cook Meredith SR. VP, GENERAL COUNSEL & SEC.
Sold on a plan
$14.11K 250 at 56.43
0.7%
Planned (10b5-1)
19 Dec 2023
Shanmugam Muthusamy HEAD OF R&D, COO-NOVITIUM OPS · indirect
Sold on a plan
$1.32M 25,000 at 52.65
2.6%
Planned (10b5-1)
18 Dec 2023
Shanmugam Muthusamy HEAD OF R&D, COO-NOVITIUM OPS · indirect
Sold on a plan
$683.08K 13,026 at 52.44
1.3%
Planned (10b5-1)
15 Dec 2023
Shanmugam Muthusamy HEAD OF R&D, COO-NOVITIUM OPS · indirect
Sold on a plan
$627.92K 11,974 at 52.44
1.2%
Planned (10b5-1)
11 Dec 2023
Cook Meredith SR. VP, GENERAL COUNSEL & SEC.
Sold on a plan
$12.30K 250 at 49.21
0.7%
Planned (10b5-1)
17 Nov 2023
Shanmugam Muthusamy HEAD OF R&D, COO-NOVITIUM OPS · indirect
Sold on a plan
$663.00K 13,000 at 51.00
1.3%
Planned (10b5-1)
16 Nov 2023
Shanmugam Muthusamy HEAD OF R&D, COO-NOVITIUM OPS · indirect
Sold on a plan
$333.10K 6,448 at 51.66
0.6%
Planned (10b5-1)
15 Nov 2023
Shanmugam Muthusamy HEAD OF R&D, COO-NOVITIUM OPS · indirect
Sold on a plan
$410.19K 7,647 at 53.64
0.8%
Planned (10b5-1)
15 Nov 2023
Davis Krista SVP, CHIEF HR OFFICER
Sold at will
$141.09K 2,622 at 53.81
7.4%
Not planned
14 Nov 2023
Shanmugam Muthusamy HEAD OF R&D, COO-NOVITIUM OPS · indirect
Sold on a plan
$1.17M 22,095 at 53.17
2.1%
Planned (10b5-1)
13 Nov 2023
Cook Meredith SR. VP, GENERAL COUNSEL & SEC.
Sold on a plan
$13.01K 250 at 52.03
0.7%
Planned (10b5-1)
Showing 101–150 of 241. ← Newer Page 3 of 5 Older →